Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report.
PTRF
congenital generalized lipodystrophy
leptin
metreleptin
Journal
Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
ISSN: 0918-5739
Titre abrégé: Clin Pediatr Endocrinol
Pays: Japan
ID NLM: 9433330
Informations de publication
Date de publication:
2019
2019
Historique:
received:
09
05
2018
accepted:
31
08
2018
entrez:
13
2
2019
pubmed:
13
2
2019
medline:
13
2
2019
Statut:
ppublish
Résumé
Congenital generalized lipodystrophy type 4 (CGL4) is a rare disease caused by mutations in the gene polymerase I and transcript release factor (
Identifiants
pubmed: 30745727
doi: 10.1297/cpe.28.1
pii: 2018-0015
pmc: PMC6356095
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1-7Références
Gut. 1975 Mar;16(3):230-4
pubmed: 1123178
N Engl J Med. 2002 Feb 21;346(8):570-8
pubmed: 11856796
J Clin Endocrinol Metab. 1954 Feb;14(2):193-204
pubmed: 13130666
J Clin Endocrinol Metab. 2007 Feb;92(2):532-41
pubmed: 17118991
J Clin Invest. 2009 Sep;119(9):2623-33
pubmed: 19726876
PLoS Genet. 2010 Mar 12;6(3):e1000874
pubmed: 20300641
Mol Genet Metab. 2010 Oct-Nov;101(2-3):233-7
pubmed: 20638880
Am J Med Genet A. 2010 Sep;152A(9):2245-53
pubmed: 20684003
J Clin Endocrinol Metab. 2011 Nov;96(11):3313-25
pubmed: 21865368
Neuromuscul Disord. 2013 May;23(5):441-4
pubmed: 23489663
BMC Med Genet. 2013 Sep 11;14:89
pubmed: 24024685
Metabolism. 2015 Jan;64(1):24-34
pubmed: 25199978
Int J Obes (Lond). 2014 Sep;38 Suppl 2:S32-8
pubmed: 25219410
Eur J Med Genet. 2015 Apr;58(4):216-21
pubmed: 25721873
Expert Opin Biol Ther. 2015 Jul;15(7):1061-75
pubmed: 26063386
Ther Clin Risk Manag. 2015 Sep 16;11:1391-400
pubmed: 26396524
Clin Endocrinol (Oxf). 2016 Jul;85(1):137-49
pubmed: 26589105
Ir J Med Sci. 1981 Mar;150(3):84-5
pubmed: 7228604